Partnering and in-licensing

We seek to maximize the potential of our pipeline through global co-development and commercialization partnerships that complement and extend our capabilities to deliver new peptide-based therapies for patients with unmet medical needs.

We also have an interest in novel ideas for biological targets which could be addressed with peptide therapeutics as well as novel peptide chemistry. In addition, we have a focus on identifying novel technologies that allow alternative routes of administration, improve drug-like properties and facilitate conjugation of additional moieties to peptides.

If you have a partnership idea or technology opportunity that you want to share with us, please contact: